# Exploring Pharmacists’ Perceptions of Their Current Role in Mental Health Trusts in England: A Qualitative Study

## TL;DR

This study explores how pharmacists in England view their roles in mental health services, highlighting their contributions and the challenges they face.

## Contribution

The study provides new insights into pharmacists' perceptions and challenges in mental health services within NHS Trusts in England.

## Key findings

- Pharmacists play key roles in medication management, clinical decisions, and patient counseling in mental health services.
- Challenges include stigma, role ambiguity, limited training, and institutional issues like workload and funding.
- Participants recommended better mental health training in pharmacy education and efforts to reduce stigma.

## Abstract

Aim: This study assessed how pharmacists perceive the impact of their role in the mental health (MH) services in two National Health Service (NHS) Trusts in England and their views on this service. Methods: An interview-based study was conducted from September to December 2023 on Microsoft Teams® by interviewing the pharmacists involved in MH services in Berkshire Healthcare NHS Foundation Trust & the Birmingham and Solihull Mental Health Trust (BSMHFT) in England. Interviews were conducted using a semi-structured interview guide containing questions related to pharmacists’ roles, activities, perceptions about the service, and future recommendations. Transcripts were prepared and analysed using thematic analysis. The study was approved by the ethics committee of the School of Pharmacy at the University of Reading and was registered as a service evaluation with both Trusts. Results: A total of 11 participants attended the interviews. Most of the participants self-identified as women (n = 9), worked between 25 and 40 h on average weekly (n = 8), and had training in MH (n = 7). Few (n = 4) had work experience >20 years. Four themes emerged: (1) Roles and responsibilities—pharmacists play a vital role in medication management, clinical decision-making, and patient counselling; (2) satisfaction and positive impacts—a high job satisfaction derived from improved patient outcomes and effective multidisciplinary collaboration was reported; (3) challenges and barriers—stigma, role ambiguity, limited training in mental health, and institutional challenges (workload, funding, etc.), were identified; participants also expressed scepticism about the readiness of newly qualified prescriber pharmacists; (4) recommendations—participants advocated for enhanced MH content in pharmacy curricula, societal awareness and de-stigmatisation. Conclusions: Pharmacists viewed their role as integral to providing MH services; however, progress is impeded by challenges such as stigma, fragmented care, training gaps, and staffing shortages. It seemed unclear at the moment how the new prescriber-ready pharmacists will contribute to services. Additional findings from primary-care settings would provide a collective account of the current roles of pharmacists and their potential in MH.